2024 年至 2032 年血小板市场机会、成长动力、产业趋势分析与预测

Blood Platelets Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: 2024年09月10日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球血小板市场价值为 56 亿美元，预计 2024 年至 2032 年复合年增长率为 4.2%。输血。慢性疾病和血液相关疾病是市场扩张的关键驱动力。影响因素包括人口老化、生活方式相关的健康挑战以及癌症发生率激增。例如，世界卫生组织报告称，心血管疾病每年导致 1,790 万人死亡，其中许多与血小板疗法有关。

人们对捐血和血小板输注的认识不断增强，正成为市场的一个突出趋势。世界捐血者日等措施有效地强调了血液和血小板捐赠的重要性。此类活动正在推动自愿捐赠，从而增加用于基本医疗治疗（包括手术和创伤护理）的血小板供应。整个产业分为血小板类型、应用、最终用途和地区。

市面上将血小板类型分为单采血小板和全血血小板。 2023 年，单采血小板领域的收入达到 30 亿美元。这种能力对于满足紧急医疗场景（例如手术和癌症治疗）对血小板的高需求至关重要。血小板的应用包括血小板减少症、血液肿瘤学、围手术期适应症、血友病、血小板功能障碍等。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	56 亿美元
预测值	83亿美元
复合年增长率	4.2%

2023年，血小板减少症细分市场以44.3%的份额引领市场。血小板减少症以血小板数量减少为标誌，通常与自体免疫疾病、感染和某些癌症等疾病有关。这种广泛发生推动了血小板输注在其管理和治疗中的强劲需求。 2023 年，北美血小板市场规模达15 亿美元，预计2024 年至2032 年复合年增长率为2.8%。患者数量的增加，疾病的增加，用于治疗和研究的血小板需求也在增加。

产业生态系统分析
产业影响力
- 成长动力
  - 慢性疾病和血液相关疾病的盛行率不断增加
  - 输血需求不断成长
  - 对捐血和血小板输注的认识提高
  - 外科手术数量不断增加
- 产业陷阱与挑战
  - 感染传播的高风险
  - 治疗费用高
成长潜力分析
监管环境
技术景观
报销场景
2021-2032 年按地区定价分析
- 北美洲
  - 我们
  - 加拿大
- 欧洲
  - 德国
  - 英国
  - 法国
  - 西班牙
  - 义大利
- 亚太地区
  - 中国
  - 日本
  - 印度
  - 澳洲
  - 韩国
- 拉丁美洲
  - 巴西
  - 墨西哥
  - 阿根廷
- MEA
  - 南非
  - 沙乌地阿拉伯
  - 阿联酋
波特的分析
PESTEL分析
未来市场趋势
差距分析

第 4 章：竞争格局

介绍
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按血小板类型，2021 - 2032

主要趋势
单采血小板
全血血小板

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
血小板减少症
血液肿瘤学
围手术期指征
血友病
血小板功能障碍
其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院
门诊手术中心
其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

American Association of Blood Banks (AABB)
American National Red Cross
America's Blood Centers
Blood Centers of America
Brazilian Red Cross
Canada Blood Services
French Red Cross
German Red Cross
Indian Red Cross Society
Italian Red Cross
Japanese Red Cross Society
OneBlood
Red Cross Society of China
South African Red Cross
Spanish Red Cross
The European Blood Alliance (EBA)

简介目录

Product Code: 2849

The Global Blood Platelets Market was valued at USD 5.6 billion in 2023 and is projected to grow at a CAGR of 4.2% from 2024 to 2032. This growth is primarily fueled by the rising prevalence of chronic and blood-related disorders, alongside an increasing demand for blood transfusions. Chronic and blood-related disorders are key drivers of market expansion. Contributing factors include an aging population, lifestyle-related health challenges, and a surge in cancer rates. For example, the World Health Organization reports that cardiovascular diseases account for 17.9 million deaths annually, many of which involve platelet therapies.

Growing awareness about blood donations and platelet transfusions is becoming a prominent trend in the market. Initiatives like World Blood Donor Day have effectively underscored the importance of blood and platelet donations. Such campaigns are boosting voluntary donations, thereby increasing the platelet supply for essential medical treatments, including surgeries and trauma care. The overall industry is segmented into platelet type, application, end-use, and region.

The market categorizes platelet types into apheresis-derived platelets and whole-blood-derived platelets. The apheresis-derived platelets segment led with a revenue of USD 3 billion in 2023. Apheresis technology enables the collection of a greater number of platelets from a single donor than traditional whole-blood donations. This capability is vital for addressing the high demand for platelets in urgent medical scenarios, such as surgeries and cancer treatments. Applications of blood platelets include thrombocytopenia, hemato-oncology, perioperative indications, hemophilia, platelet function disorders, and others.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$5.6 Billion
Forecast Value	$8.3 Billion
CAGR	4.2%

In 2023, the thrombocytopenia segment led the market with a 44.3% share. Thrombocytopenia, marked by a reduced platelet count, is commonly linked to disorders like autoimmune diseases, infections, and certain cancers. This widespread occurrence drives a robust demand for platelet transfusions in its management and treatment. North America blood platelets market accounted for USD 1.5 billion in 2023, with projections of a 2.8% CAGR from 2024 to 2032. The region sees a notable incidence of blood disorders, including leukemia and lymphoma.As the number of cancer patients and individuals with blood disorders rises, so does the demand for blood platelets for both treatments and research.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic and blood-related disorders
  - 3.2.1.2 Growing demand for blood transfusions
  - 3.2.1.3 Rise in awareness regarding blood donations and platelets transfusions
  - 3.2.1.4 Rising number of surgical procedures
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High risk of transmissions of infections
  - 3.2.2.2 High cost of the treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Pricing analysis, by region, 2021-2032
- 3.7.1 North America
  - 3.7.1.1 U.S.
  - 3.7.1.2 Canada
- 3.7.2 Europe
  - 3.7.2.1 Germany
  - 3.7.2.2 UK
  - 3.7.2.3 France
  - 3.7.2.4 Spain
  - 3.7.2.5 Italy
- 3.7.3 Asia Pacific
  - 3.7.3.1 China
  - 3.7.3.2 Japan
  - 3.7.3.3 India
  - 3.7.3.4 Australia
  - 3.7.3.5 South Korea
- 3.7.4 Latin America
  - 3.7.4.1 Brazil
  - 3.7.4.2 Mexico
  - 3.7.4.3 Argentina
- 3.7.5 MEA
  - 3.7.5.1 South Africa
  - 3.7.5.2 Saudi Arabia
  - 3.7.5.3 UAE
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Future market trends
3.11 Gap analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Competitive positioning matrix
4.3 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Platelet type, 2021 - 2032 ($ Mn & Units)

5.1 Key trends
5.2 Apheresis derived platelets
5.3 Whole blood derived platelet

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Thrombocytopenia
6.3 Hemato-oncology
6.4 Perioperative indications
6.5 Hemophilia
6.6 Platelet function disorders
6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa